ALGIECEL™ | Securing CO2 Neutrality
+45 2248 5667
Send e-mail
Application
Vision
Securing CO2 Neutrality
Mission
Our goal is to remove millions of tonnes of CO2 annually from industrial production without hurting our clients´ bottom lines
Our Core Values
Planetary health is in everybody´s interest
Not bound by business as usual
Customer service is in our DNA
Work life balance & ownership mentality
Trust and support
Remember to have fun
THE COMPANY TODAY
ALGIECEL was founded in May 2021 to secure industrial CO2 neutrality by implementation of microalgae-based Carbon Capture and Utilization (CCU).
We have recently finished the design, construction and installation of a pilot plant of our modular and easy-to-install PhotoBioReactor (PBR) solution at the Danish Technological Institute (DTI).
A skilled team with the necessary experience has been built. The company has received funding from the BioInnovation Institute (BII), and we participate in the Venture Lab program since March 2022.
In January 2023, ALGIECEL closed a DKK 10 million (EUR 1.3m) seed round in combined funding from Denmark’s Export and Investment Fund and a UK-based family fund.
ALGIECEL has entered into supplier agreements with partners that hold key insights into areas such as LED light, biotech and plastic.
LOIs with potential clients and product end-users have been secured. A venue for the demo-scale project has been secured at a Novozymes facility.
THE PILOT PROJECT
In June 2022 ALGIECEL celebrated the opening of the mobile pilot plant at the Danish Technological Institute with more than 70 participants.
The day was dedicated to the green transition and sustainability with ALGIECEL´s development of a mobile container-based solution for the conversion of CO2 into biomass.
The pilot photobioreactor is now set up in cooperation with the DTI, which has secured access to laboratories, facilities and competencies within the microalgae cultivation area.
CEO Juan Farré from the DTI stated that “the opening marks the establishment by the DTI of an ecosystem giving start-up companies access to an integrated platform of testing and demonstration facilities within the space of future foods and the green transition”.
Earlier this year BII invested in ALGIECEL, and during the opening ceremony Jens Nielsen, the CEO of BII, kindly remarked: “I am impressed to see how rapidly ALGIECEL has advanced and is now initiating experiments at pilot scale. But speed is unfortunately important as we rapidly need new technologies like the ones ALGIECEL is providing to make sure that we can create a sustainable society. I congratulate them with their advancements, and I will be looking much forward to following them in the years to come”.
Meet the Management & Board
Management Team
Henrik Busch-Larsen
CEO / Founder / Board Member
Entrepreneur, Strategy, Vision, Execution, Scale-up
Prior experience with
CEO Unibio Group, Co-founder A21 Systems, Various Board Positions
Jesper Svarer
CFO
Experience from international senior leadership roles within Finance, Strategy, M&A and business development.
Prior experience with:
Falck, KMD, A.P. Moller-Maersk, ISS, Handelsbanken
Christian Kølby
CTO
Civil Engineer, MSc., Biotechnology and Aquaculture
Prior experience with:
Nestlé, SPX, Arla Foods Ingredients, Danisco, professional experience with pilot plants, R&D, food application technology and product management
Gry Husby Larsen
SVP Legal & HR
Lawyer, General Counsel
Prior experience with:
FluoGuide, BioPorto, Unibio, Knop & Co Advokater, DTU, Rigshospitalet
Jens Odgaard Olsson
Head of Commercial
Agricultural Value Chains, Experience Economics, Brand Development
Prior experience with:
Arla Foods, Carlsberg Group, Pernod Ricard & Lantmännen
Board of Directors
Martin Lavesen
Chairman of the Board
Managing Partner @DLA Piper Denmark
Prior experience with:
+25 years as commercial lawyer focusing on IPR, Various board positions
Jeppe Høier
Board Member
Investor
Investor background from: Sunstone Life Science Ventures, Heartcore Maersk Growth. Led Unicorn rounds in companies such as Einride and Forto
Advisory Board
Per Møller
Senior Symbiosis Developer @Kalundborg Symbiosis
Industrial Symbiosis, Marine Biology, Microalgae downstream processing, Chemical Engineering
Dr. Dorinde Kleinegris
Principal Investigator Microalgae @NORCE, Associate Prof. Marine Biotechnology at the University of Bergen (secondary position)
Bioprocess Engineering, Microalgae cultivation & strain selection, Techno-economic & LCA
Stephan Freyer
Senior Research Manager @BASF
Bioprocess Development, Scale-Up, Fermentation, Media Optimization
Dr. Andreas Worberg
CCO @The Novo Nordisk Foundation Center for BiosustainabilityCCO @DTU Biosustain, CTO @Cellugy ApS
Process Development in Biomanufacturing, Business Development
Michael Stannius Aagren
Digitalization Manager @Unibio
Industrial Production, Digitalization & IT
DIVERSITY POLICY
Algiecel is committed to continue working towards ensuring and furthering equal opportunities for all employees in respect of differences, such as gender, age, religion, sexual orientation and ethnicity, as all – in our view – serve as key components in ensuring a better, more dynamic and healthier business.
The view extended through this policy also includes maintaining equal opportunities for women and men at all management levels in Algiecel. The Board of Directors annually discusses the company’s activities to ensure relevant diversity at management levels and evaluates the policy on diversity.
Algiecel has defined a target, that no later than in 2025, at the composition of genders shall be no less than 25%/75% both in the Management of the Company and Board of Directors. This target must not detract from other competency requirements in the nomination of members to the Management team of the Company.
